• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, April 26

Hyderabad-based Suven Life Sciences posted a 24-per-cent increase in net profit at Rs 2.81crore in the fourth quarter of last fiscal ended March 2007 as against Rs 2.26 crore in the corresponding period of the previous fiscal.

According to a release issued here on Thursday, during the quarter, revenues surged 47 per cent to Rs 28.73 crore (Rs 19.56 crore). In 2006-07, the firm's profit after tax (PAT) grew 33 per cent to Rs 11.22 crore (Rs 8.46 crore). Revenues increased 38 per cent to Rs 114.58 crore (Rs 83 crore). Exports too climbed 38 per cent to Rs 87.87 crore (Rs 63.69 crore). During the period under review, the company continued to focus on drug discovery and had spent about 24 per cent of its revenue on R&D, the release added.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Reliance full year net tops Rs 10,000 crore

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line